Brief: Celltrion Pharm 2025 Operating Profit 56 Billion Won, Up 50.7% From Year Earlier
05/02/2026 02:04
Celltrion Pharm Inc 068760.KQ: CELLTRION PHARM: 2025 OPERATING PROFIT 56 BILLION WON, UP 50.7% FROM YEAR EARLIER Source text: [ID:] Further company coverage: 068760.KQ
Recent news on Celltrion Pharm
See all newsBrief: Celltrion Pharm To Invest 2 Trln Won In Global Pfs Production Facility In Chungcheong
Brief: Celltrion Pharm To Cancel 14 Billion Won Worth Of Own Shares
Brief: Celltrion Pharm 2025 Operating Profit 56 Billion Won, Up 50.7% From Year Earlier
South Korea approves Celltrion's COVID-19 treatment for use
S.Korea Celltrion's candidate COVID-19 drug gets approval for special-case use